Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior.


Journal

The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 20 11 2018
medline: 10 1 2020
entrez: 20 11 2018
Statut: ppublish

Résumé

Pheochromocytomas (PCCs) and abdominal paragangliomas (PGLs), collectively abbreviated PPGL, are believed to exhibit malignant potential-but only subsets of cases will display full-blown malignant properties. The Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) algorithm is a proposed histologic system to detect potential for aggressive behavior, but little is known regarding the coupling to underlying molecular genetics. In this study, a total of 92 PPGLs, previously characterized for susceptibility gene status and mRNA expressional profiles, were histologically assessed using the PASS criteria. A total of 32/92 PPGLs (35%) exhibited a PASS score ≥4, including all 8 cases with malignant behavior (7 with known metastases and 1 with extensively infiltrative local recurrence). Statistical analyzes between expressional data and clinical parameters as well as individual PASS criteria yielded significant associations to Chromogranin B (CHGB), BRCA2, HIST1H3B, BUB1B, and RET to name a few, and CHGB had the strongest correlation to both PASS and metastasis/local recurrence of all analyzed genes. Evident CHGB downregulation was observed in PPGLs with high PASS and overtly malignant behavior, and was also associated with shorter disease-related survival. This finding was validated using quantitative real-time polymerase chain reaction, in which CHGB expression correlated with both PASS and metastasis/local recurrence with consistent findings obtained in the TCGA cohort. Moreover, immunohistochemical analyses of subsets of tumors showed a correlation between high PASS scores and negative or weak CHGB protein expression. Patients with PPGLs obtaining high PASS scores postoperatively, also exhibited low preoperative plasma levels of CHGB. These data collectively point out CHGB as a possible preoperative and postoperative marker for PPGLs with potential for aggressive behavior.

Identifiants

pubmed: 30451732
doi: 10.1097/PAS.0000000000001190
doi:

Substances chimiques

Biomarkers, Tumor 0
CHGB protein, human 0
Chromogranin B 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

409-421

Auteurs

Adam Stenman (A)

Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, CCK.

Fredrika Svahn (F)

Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, CCK.

Mohammad Hojjat-Farsangi (M)

Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, CCK.
Department of Immunology, The Persian Gulf Marine Biotechnology Medicine Research Center, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.

Jan Zedenius (J)

Department of Molecular Medicine and Surgery, Karolinska Institutet.
Department of Breast and Endocrine Surgery, Karolinska University Hospital.

Peter Söderkvist (P)

Department of Clinical and Experimental Medicine, Division of Cell Biology.

Oliver Gimm (O)

Department of Clinical and Experimental Medicine, Division of Cell Biology.
Department of Surgery, Medical Faculty, Linköping University, Linköping, Sweden.

Catharina Larsson (C)

Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, CCK.

C Christofer Juhlin (CC)

Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, CCK.
Department of Pathology and Cytology, Karolinska University Hospital, Stockholm.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH